Urology · North Miami, FL
NPI
1588848683
Since 2007
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
12411 Biscayne Blvd
North Miami, FL, 33181
Phone (305) 672-4222
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,334 services
Medicare patients, 2024
324
Average age 75
Drug cost, 2024
$2.5M
2,863 prescriptions
Company payments, 2025
$1,007
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Robbins was code 81002 (clinical chemistry), 400 times for 235 patients. In total David A Robbins billed 1,334 services in 42 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 400 | 235 | $3.41 | $1,364 |
| 99213 Office E&M - Established | Office | 356 | 211 | $74.88 | $27K |
| 99204 Office E&M - New | Office | 99 | 99 | $138.45 | $14K |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 64 | 59 | $2.04 | $130 |
| 96372 Injection Administration | Office | 62 | 58 | $11.77 | $730 |
| 52000 Cystourethroscopy | Office | 61 | 58 | $198.45 | $12K |
| 99214 Office E&M - Established | Office | 42 | 42 | $103.79 | $4,359 |
| 99223 Hospital E&M - Initial | Facility | 28 | 28 | $145.04 | $4,061 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 27 | 26 | $88.34 | $2,385 |
| 76872 Ultrasound - Nonspecific | Office | 19 | 18 | $111.98 | $2,128 |
By year: 2022 $110K for 1,370 services; 2023 $91K for 1,210 services; 2024 $95K for 1,334 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 400 | 235 | $3.41 | $1,364 |
Medicare prescription drug claims, 2024
In 2024, the drug David A Robbins prescribed most often to Medicare patients was Tamsulosin Hcl, with 533 prescriptions and refills. In total David A Robbins wrote 2,863 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 533 | 1,494 | 265 | $5,179 |
| Finasteride Generic | 294 | 836 | 140 | $3,819 |
| Cefuroxime Cefuroxime Axetil | 251 | 251 | 221 | $3,396 |
| Lupron Depot Leuprolide Acetate | 178 | 530 | 127 | $1.1M |
| Myrbetriq Mirabegron | 177 | 294 | 60 | $129K |
| Trelstar Triptorelin Pamoate | 176 | 495 | 64 | $441K |
| Sildenafil Citrate Generic | 174 | 214 | 63 | $1,088 |
| Gemtesa Vibegron | 171 | 335 | 77 | $158K |
| Testosterone Cypionate Generic | 106 | 116 | 23 | $2,940 |
| Doxycycline Hyclate Generic | 94 | 94 | 78 | $543 |
| Estradiol Generic | 92 | 292 | 54 | $5,256 |
| Bicalutamide Generic | 90 | 149 | 47 | $2,314 |
| Tramadol Hcl Generic | 84 | 84 | 83 | $116 |
| Tadalafil Generic | 65 | 73 | 23 | $3,661 |
| Cephalexin Generic | 45 | 45 | 43 | $252 |
Brand drugs: 797 claims; generic drugs: 2,066 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Robbins $1,007 ($1,007 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $278.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 23 | $278 |
| Boston Scientific Corporation BSX | 14 | $191 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $104 |
| Astellas Pharma US Inc 4503.T | 3 | $89.32 |
| Endo USA, Inc. | 3 | $80.96 |
| Procept Biorobotics Corporation PRCT | 2 | $41.82 |
| Abbvie Inc. ABBV | 2 | $40.75 |
| Teleflex LLC TFX | 1 | $36.63 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $29.21 |
| Blue Earth Diagnostics | 1 | $26.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.